{"id":"NCT01322347","sponsor":"Rockwell Medical Technologies, Inc.","briefTitle":"Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients (CRUISE 2)","officialTitle":"A Randomized, Placebo-Controlled, Phase III Study of Dialysate Containing Soluble Ferric Pyrophosphate (SFP) in Chronic Kidney Disease Patients Receiving Hemodialysis: The Continuous Replacement Using Iron Soluble Equivalents (CRUISE 2) Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-04","primaryCompletion":"2014-01","completion":"2014-02","firstPosted":"2011-03-24","resultsPosted":"2015-04-24","lastUpdate":"2017-04-26"},"enrollment":294,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Renal Failure Chronic Requiring Hemodialysis"],"interventions":[{"type":"DRUG","name":"Soluble Ferric Pyrophosphate (SFP)","otherNames":[]},{"type":"DEVICE","name":"Standard dialysate","otherNames":[]}],"arms":[{"label":"Soluble Ferric Pyrophosphate (SFP) in dialysate","type":"ACTIVE_COMPARATOR"},{"label":"Standard Dialysate","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to confirm the safety and efficacy of Soluble Ferric Pyrophosphate (SFP) dialysate solution in maintaining iron delivery for erythropoiesis in anemic adult patients with chronic kidney disease (CKD) receiving hemodialysis. Efficacy will be measured primarily by the change from baseline in hemoglobin (Hgb).","primaryOutcome":{"measure":"Change From Baseline Hemoglobin at End-of-Treatment: Least-Squares Mean","timeFrame":"Hgb measured weekly; up to 48 weeks from date of randomization","effectByArm":[{"arm":"Stage 2 Soluble Ferric Pyrophosphate (SFP) in Dialysate","deltaMin":-0.5,"sd":1.08},{"arm":"Stage 2 Placebo (Standard Dialysate)","deltaMin":-4,"sd":1.09}],"pValues":[{"comp":"OG000 vs OG001","p":"0.011"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":13},"locations":{"siteCount":40,"countries":["United States","Canada"]},"refs":{"pmids":["26175145"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":36,"n":145},"commonTop":["PROCEDURAL HYPOTENSION","ARTERIOVENOUS FISTULA SITE COMPLICATION","HAEMODIALYSIS-INDUCED SYMPTOM","NAUSEA","HEADACHE"]}}